NEOGENOMICS INC — Director's Dealing 2018

May 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-05-25

Reporting Person: CARDOZA GEORGE (President, Pharma Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-25	Common Stock	M	8333	—	Acquired	197422	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-25	Restricted Stock	$0.0	M	8333	Disposed		Common Stock (8333.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (200000.0)	200000	Direct
Stock Option (Right to Buy)	$3.45	2019-03-05	Common Stock (30000.0)	30000	Direct
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (200000.0)	200000	Direct
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (200000.0)	200000	Direct
Stock Options (Right to Buy)	$8.03	2023-02-26	Common Stock (192500.0)	192500	Direct

Footnotes

F1: Each share of restricted stock represents the contingent right to receive one share of common stock upon vesting.

F2: Restricted stock will vest as follows; 8,333 shares vested on May 25, 2018, 8,333 shares will vest on May 25, 2019 and 8,334 shares will vest on May 25, 2020.

F3: These restricted shares will terminate upon the earliest of death, termination of employment or the last vesting date.

F4: On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably over the first three anniversary dates of the grant.

F6: On May 4, 2015 Mr. Cardoza was granted an option to purchase 200,000 shares. These options vest ratably over the first three anniversary dates of the grant.

F7: On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.

F8: On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.